Page 4 - Sebco-4pp-latest
P. 4

Coconut Oil         For more details, contact us:
                       Compound            E:  info@dermauk.co.uk

                       Coal Tar Solution 12% w/w  W:  dermauk.co.uk/sebco
                       Salicylic Acid 2% w/w  T:  0191 375 9020
                       Sulfur for External Use 4% w/w
                    Abbreviated Prescribing Information for Sebco
                                           TM
                    Please refer to the full Summary of Product Characteristics (SmPC) prior to prescribing.
                    Presentation: Ointment containing coal tar solution 12%, salicylic acid 2%, sulfur for external use 4%. Uses: Treatment of common scaly scalp
                    disorders such as psoriasis, eczema, seborrheic dermatitis and dandruff.  Dosage: Gently rub into scalp, leave in contact for approximately
                    one hour. Wash out using warm water and mild shampoo. For severe scalp conditions, use daily for 3-7 days until improvement is obtained
                    then intermittently as necessary. For less severe conditions such as dandruff use intermittently as necessary, e.g., once a week. If symptoms
                    persist after 4 weeks consult your doctor. For children 6-12 years use under medical supervision only. Not recommended for use on children
                    under six years. Contraindications: Skin infections of the scalp or known sensitivity to any of the ingredients. Use in Pregnancy and
                    Lactation: To be used at the discretion of the prescribing doctor. Warnings and Precautions: Instruct patients not to smoke or go near
                    naked flames - risk of severe burns. Fabric (clothing, bedding, dressings etc) that has been in contact with this product burns more easily and
                    is a serious fire hazard. Washing clothing and bedding may reduce product build-up but not totally remove it. Avoid contact with eyes, and
                    any areas of broken skin. Coal tar may stain clothes and jewellery. Remove or protect these items during treatment. Side Effects: May cause
                    skin irritation, folliculitis and rarely photosensitivity. In the event of such a reaction, discontinue use. Prescribers should consult the Summary
                    of Product Characteristics in relation to other side effects. Pharmaceutical Precautions: Store below 25°C. Do not refrigerate. Replace the
                    cap after use and return tube to carton. Discard tube no later than 4 weeks after opening.  Package Quantities: 100g tube, 40g tube. Basic
                    NHS Price: 40g £10.41, 100g £15.88. Legal Category: GSL. Marketing Authorisation Number: PL 19876/0001. Full prescribing information
                    is available on request. Marketing Authorisation Holder: Derma UK Ltd, The Toffee Factory, Lower Steenbergs Yard, Ouseburn, Newcastle
                    upon Tyne NE1 2DF, UK. “Sebco” and “Derma UK” are registered Trademarks Date of Revision of Text: January 2024. Further information can
                    be found in the Summary of Product Characteristics or from: Derma UK Ltd, The Toffee Factory, Lower Steenbergs Yard, Quayside, Ouseburn,
                    Walker Rd, Newcastle upon Tyne, Tyne and Wear, NE1 2DF.
                           Adverse events should be reported. Information about adverse event reporting can be found at
                        www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Derma UK Ltd, UK on 0191 375 9020.
          Another trusted
          product from            References: 1. National Institute for Health and Care Excellence, Psoriasis,
                              https://bnf.nice.org.uk/treatment-summary/psoriasis.html, (last accessed 15th January 2024)
                                    2. National Institute for Health and Care Excellence, Psoriasis,
                                https://cks.nice.org.uk/psoriasis#!scenario:2 (last accessed 15th January 2024)
                                   3. National Institute for Health and Care Excellence, BROWSE DRUGS,
                                    https://bnf.nice.org.uk/drug/, (last accessed 15th January 2024)
                    SEB/89/01244                                                                                                                             Date of Preparation: January 2024
   1   2   3   4